KARA HERRERA: Open Payments
NPI 1821074543 · ROUND ROCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,025 in 174 payments from 19 companies in 2025. Trend: 2023 $2,048 · 2024 $2,724 · 2025 $3,025
Food & beverage: $3,025
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $528 |
| PFIZER INC. | 35 | $444 |
| Janssen Biotech, Inc. | 17 | $371 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 29 | $256 |
| QOL Medical, LLC | 8 | $234 |
| Madrigal Pharmaceuticals | 12 | $225 |
| GENZYME CORPORATION | 9 | $223 |
| Celltrion USA Inc. | 10 | $164 |
| Ardelyx, Inc. | 8 | $159 |
| Regeneron Healthcare Solutions, Inc. | 3 | $108 |
Products named: VELSIPITY, TREMFYA, MAVYRET, DUPIXENT, XIFAXAN, Sucraid, REZDIFFRA, VEGZELMA.
Industry payments across TX — which companies pay providers there.
